Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

United Therapeutics (UTHR) Long-Term Deferred Tax (2016 - 2025)

Historic Long-Term Deferred Tax for United Therapeutics (UTHR) over the last 17 years, with Q3 2025 value amounting to $354.9 million.

  • United Therapeutics' Long-Term Deferred Tax fell 920.95% to $354.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $354.9 million, marking a year-over-year decrease of 920.95%. This contributed to the annual value of $458.4 million for FY2024, which is 1610.94% up from last year.
  • As of Q3 2025, United Therapeutics' Long-Term Deferred Tax stood at $354.9 million, which was down 920.95% from $456.2 million recorded in Q2 2025.
  • United Therapeutics' Long-Term Deferred Tax's 5-year high stood at $458.4 million during Q4 2024, with a 5-year trough of $261.9 million in Q4 2021.
  • For the 5-year period, United Therapeutics' Long-Term Deferred Tax averaged around $341.9 million, with its median value being $325.6 million (2023).
  • As far as peak fluctuations go, United Therapeutics' Long-Term Deferred Tax soared by 2512.41% in 2022, and later plummeted by 920.95% in 2025.
  • Quarter analysis of 5 years shows United Therapeutics' Long-Term Deferred Tax stood at $261.9 million in 2021, then grew by 25.12% to $327.7 million in 2022, then rose by 20.48% to $394.8 million in 2023, then increased by 16.11% to $458.4 million in 2024, then dropped by 22.58% to $354.9 million in 2025.
  • Its Long-Term Deferred Tax stands at $354.9 million for Q3 2025, versus $456.2 million for Q2 2025 and $456.6 million for Q1 2025.